Awards, clinical progress and partnerships from the AIMALABS team.
Dr Vasiliki Vlacha, lead researcher on AI-based blood smear identification, was selected among the top 30 at the VivaTech Women Founder Award — recognition for the research behind AIMALABS.
AIMALABS is in discussion with NHS trusts about research collaboration on AI-based blood smear identification, alongside NHS Innovation support.
Dr Vasiliki Vlacha received first prize at the Behealth Start-Up Competition for the research on AI-based blood smear identification.
The research programme joined ConceptionX’s deep-tech medical cohort, adding venture-building support.
Research validation of the underlying models is underway at Aigion Hospital, comparing the models against two biopathologists on matched smears, with further studies arranged at Amaliada Hospital and the German Medical Institute of Cyprus.
The research on AI-based blood smear identification received the 2nd Award at Pfizer’s Start4Health acceleration lab, alongside non-dilutive support for its early development.
Reach out to receive updates, or to explore a clinical or investment partnership.
Get in touch →